Investigating brain iron levels as a marker for cognitive issues in children who survived brain tumors

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors

NIH-funded research Children's Hospital of Los Angeles · NIH-10448295

This study is looking at kids who survived brain tumors and had radiation treatment, to see how it affects their thinking skills by checking for iron buildup in their brains, which might help us find ways to support their cognitive health and improve their lives.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionChildren's Hospital of Los Angeles NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-10448295 on NIH RePORTER

What this research studies

This research focuses on pediatric brain tumor survivors who have undergone cranial radiation therapy, a common treatment that can lead to neurocognitive deficits. By using advanced MR imaging techniques, specifically quantitative susceptibility mapping (QSM), the study aims to measure iron accumulation in the brain, which may serve as a biomarker for cognitive dysfunction. The research will collect both imaging and neuropsychological data to understand the long-term effects of radiation therapy on cognitive health. This could help in developing targeted interventions to improve the quality of life for these survivors.

Who could benefit from this research

Good fit: Ideal candidates for this research are children who have survived brain tumors and received cranial radiation therapy.

Not a fit: Patients who have not undergone cranial radiation therapy or do not have a history of brain tumors may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of cognitive impairments in pediatric brain tumor survivors.

How similar studies have performed: Other research has shown promising results in using iron accumulation as a biomarker in neurodegenerative diseases, suggesting potential for success in this novel application.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's DiseaseAlzheimer diseaseAlzheimer syndromeAlzheimer's disease dementiaAlzheimers disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.